Cleared Traditional

K860768 - DIRECTIGEN COMBO MENINGITIS TEST (FDA 510(k) Clearance)

May 1986
Decision
71d
Days
Class 1
Risk

K860768 is an FDA 510(k) clearance for the DIRECTIGEN COMBO MENINGITIS TEST. This device is classified as a Antisera, All Groups, Streptococcus Spp. (Class I - General Controls, product code GTZ).

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Paramus, US). The FDA issued a Cleared decision on May 13, 1986, 71 days after receiving the submission on March 3, 1986.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3740.

Submission Details

510(k) Number K860768 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 1986
Decision Date May 13, 1986
Days to Decision 71 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GTZ — Antisera, All Groups, Streptococcus Spp.
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3740